DENTSPLY SIRONA financials
$8.98−3.23%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $898.0M | $880.0M | $961.0M | $904.0M | $936.0M | $879.0M | $905.0M | $951.0M | $984.0M | $953.0M | $1.01B | $947.0M |
| Gross profit | $493.0M | $427.0M | $443.0M | $441.0M | $490.0M | $466.0M | $446.0M | $495.0M | $511.0M | $506.0M | $522.0M | $495.0M |
| Gross margin | 54.9% | 48.5% | 46.1% | 48.8% | 52.4% | 53.0% | 49.3% | 52.1% | 51.9% | 53.1% | 51.6% | 52.3% |
| Operating income | $82.0M | -$35.0M | -$139.0M | -$218.0M | -$128.0M | $63.0M | -$509.0M | -$462.0M | $50.0M | $42.0M | $73.0M | -$236.0M |
| Net income | $37.0M | -$10.0M | -$146.0M | -$427.0M | -$45.0M | $20.0M | -$430.0M | -$494.0M | -$4.0M | $18.0M | $67.0M | -$266.0M |
| Net margin | 4.1% | −1.1% | −15.2% | −47.2% | −4.8% | 2.3% | −47.5% | −51.9% | −0.4% | 1.9% | 6.6% | −28.1% |
| Diluted EPS | $0.18 | $-0.05 | $-0.73 | $-2.14 | $-0.22 | $0.10 | $-2.18 | $-2.46 | $-0.02 | $0.09 | $0.32 | $-1.25 |
| EBITDA | $169.0M | $111.0M | $113.0M | $141.0M | $199.0M | $151.0M | $91.0M | $154.0M | $157.0M | $135.0M | $70.0M | $165.0M |
| Operating cash flow | $99.0M | $40.0M | $101.0M | $79.0M | $48.0M | $7.0M | $87.0M | $141.0M | $208.0M | $25.0M | $160.0M | $134.0M |
| Free cash flow | $55.0M | -$12.0M | $60.0M | $40.0M | $16.0M | -$12.0M | $36.0M | $98.0M | $156.0M | -$9.0M | $120.0M | $97.0M |
| Diluted shares | 200.5M | 199.9M | 199.0M | 199.5M | 199.3M | 199.8M | 197.7M | 201.0M | 205.6M | 208.5M | 208.6M | 211.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $239.0M | $190.0M | $326.0M | $363.0M | $359.0M | $398.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.22B | $2.24B | $2.33B | $2.40B | $2.40B | $2.33B |
| Total assets | $5.20B | $5.23B | $5.43B | $5.65B | $6.07B | $6.05B |
| Total liabilities | $3.85B | $3.91B | $4.09B | $4.17B | $4.11B | $4.04B |
| Shareholders' equity | $1.35B | $1.32B | $1.34B | $1.48B | $1.96B | $2.01B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology